ERIC 2018 | Resistance mechanisms in CLL

Richard Rosenquist

Relapsed chronic lymphocytic leukemia (CLL) patients exhibit unforeseen aberrations in ribosomal genes, says Richard Rosenquist, MD, PhD, of the Karolinska University Hospital, Solna, Sweden. Prof. Rosenquist further expresses his hope of understanding resistance mechanisms in CLL using next-generation sequencing, at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

Share this video